Dürschmied, D., Weidner, K., & Nitschmann, S. (2025). Semaglutide for heart failure with preserved ejection fraction (HFpEF): Kommentar. Die Innere Medizin, 66(2), . https://doi.org/10.1007/s00108-024-01844-7
Chicago Style (17th ed.) CitationDürschmied, Daniel, Kathrin Weidner, and Sirka Nitschmann. "Semaglutide for Heart Failure with Preserved Ejection Fraction (HFpEF): Kommentar." Die Innere Medizin 66, no. 2 (2025). https://doi.org/10.1007/s00108-024-01844-7.
MLA (9th ed.) CitationDürschmied, Daniel, et al. "Semaglutide for Heart Failure with Preserved Ejection Fraction (HFpEF): Kommentar." Die Innere Medizin, vol. 66, no. 2, 2025, https://doi.org/10.1007/s00108-024-01844-7.
Warning: These citations may not always be 100% accurate.